Therapy of hepatocellular carcinoma

A. Peracchia, L. Bolondi, M. Colombo, A. Corinaldesi, M. Cottone, W. Grigioni, T. Livraghi, A. Mazziotti, C. Rossi, V. Suraci

Research output: Contribution to journalArticlepeer-review


A great deal of experience has been accumulated in the last few years on several therapeutic modalities for the treatment of hepatocellular carcinoma (HCC): percutaneous ethanol injection, transarterial chemoembolisation, surgical resection and liver transplant. There are, however, no conclusive data, derived from prospective randomised controlled trials, to establish the best treatment or the most suitable combination of treatments. This Report analyses the current guidelines for screening patients, early detection and staging, as well as therapeutic timing and decision. The therapeutic strategy of HCC is greatly influenced by the presence and severity of liver cirrhosis, which is associated with the neoplasm in the large majority of patients. Surgical resection is the best treatment when the neoplasm arises on a normal liver. On the other hand many controversies still exist concerning the choice of treatment for HCC developing in cirrhotic livers. It is well accepted that surgical resection and percutaneous ethanol injection are effective in improving survival of unifocal small (

Original languageEnglish
Pages (from-to)221-229
Number of pages9
JournalGastroenterology International
Issue number4
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Therapy of hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this